Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
주식 순위 #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
주가
$62.83
시가총액
$93.23B
변동 (1일)
-9.17%
변동 (1년)
-31.36%
국가
US
거래 Boston Scientific Corporation (BSX)

카테고리

Boston Scientific Corporation (BSX)의 영업이익률
April 2026 기준 영업이익률 TTM: 19.78%
Boston Scientific Corporation의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 19.78%입니다. 2024년 말 기준 영업이익률은 15.73%였습니다.
Boston Scientific Corporation의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
2026 (TTM) 19.78% 0.00%
2025 19.78% 25.75%
2024 15.73% 2.68%
2023 15.32% 6.54%
2022 14.38% -11.07%
2021 16.17% 166.83%
2020 6.06% -62.01%
2019 15.95% -9.79%
2018 17.68% 4.93%
2017 16.85% 14.31%
2016 14.74% 39.45%
2015 10.57% -7.69%
2014 11.45% -6.07%
2013 12.19% -11.09%
2012 13.71% -6.92%
2011 14.73% 7.13%
2010 13.75% -13.58%
2009 15.91% -1.12%
2008 16.09% 13.95%
2007 14.12% -10.58%
2006 15.79% -50.98%
2005 32.21% 2.29%
2004 31.49% 57.06%
2003 20.05% -4.07%
2002 20.90% 458.82%
2001 3.74% -85.24%
2000 25.34% 0.00%
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
18.16% -99.08%
US
22.44% -98.87%
US
17.86% -99.10%
IE
17.86% -99.10%
IE
14.72% -99.26%
DE
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.